Jmac Enterprises LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 5.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,467 shares of the company’s stock after selling 516 shares during the period. Jmac Enterprises LLC’s holdings in Colgate-Palmolive were worth $879,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Principal Financial Group Inc. boosted its holdings in Colgate-Palmolive by 4.9% during the third quarter. Principal Financial Group Inc. now owns 997,147 shares of the company’s stock worth $103,514,000 after purchasing an additional 46,944 shares during the last quarter. Montecito Bank & Trust increased its position in shares of Colgate-Palmolive by 75.2% during the 3rd quarter. Montecito Bank & Trust now owns 11,302 shares of the company’s stock worth $1,173,000 after purchasing an additional 4,851 shares during the last quarter. BNC Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $2,053,000. Graypoint LLC boosted its holdings in shares of Colgate-Palmolive by 3.7% in the 3rd quarter. Graypoint LLC now owns 6,007 shares of the company’s stock valued at $624,000 after buying an additional 214 shares during the last quarter. Finally, Forte Capital LLC ADV grew its stake in shares of Colgate-Palmolive by 2.5% in the third quarter. Forte Capital LLC ADV now owns 18,506 shares of the company’s stock valued at $1,921,000 after buying an additional 460 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on CL. Piper Sandler started coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price target on the stock. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Wednesday. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Barclays raised their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Evercore ISI raised their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $105.11.
Insiders Place Their Bets
In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.37% of the company’s stock.
Colgate-Palmolive Stock Up 1.4 %
Colgate-Palmolive stock opened at $91.52 on Thursday. Colgate-Palmolive has a fifty-two week low of $74.67 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The firm’s 50-day simple moving average is $101.49 and its 200 day simple moving average is $98.39. The stock has a market cap of $74.77 billion, a PE ratio of 25.85, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Election Stocks: How Elections Affect the Stock Market
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Reasons To Like Coinbase After The Election, 1 to Still Avoid
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.